机译:炎症性肠疾病患者中非常低容量肠道制剂的功效和耐受性
Univ Roma Tor Vergata Dept Syst Med Gastroenterol Unit Via Montpellier 1 I-00133 Rome Italy;
Univ Roma Tor Vergata Dept Syst Med Gastroenterol Unit Via Montpellier 1 I-00133 Rome Italy;
IRCCS Rome Regina Elena Natl Canc Inst UOSD Clin Trial Ctr Dept Biostat &
Bioinformat Rome;
Univ Roma Tor Vergata Dept Syst Med Gastroenterol Unit Via Montpellier 1 I-00133 Rome Italy;
Univ Roma Tor Vergata Dept Syst Med Gastroenterol Unit Via Montpellier 1 I-00133 Rome Italy;
Univ Roma Tor Vergata Dept Syst Med Gastroenterol Unit Via Montpellier 1 I-00133 Rome Italy;
Univ Roma Tor Vergata Dept Syst Med Gastroenterol Unit Via Montpellier 1 I-00133 Rome Italy;
Univ Roma Tor Vergata Dept Syst Med Gastroenterol Unit Via Montpellier 1 I-00133 Rome Italy;
Univ Roma Tor Vergata Dept Syst Med Gastroenterol Unit Via Montpellier 1 I-00133 Rome Italy;
Univ Roma Tor Vergata Dept Syst Med Gastroenterol Unit Via Montpellier 1 I-00133 Rome Italy;
Univ Roma Tor Vergata Dept Syst Med Gastroenterol Unit Via Montpellier 1 I-00133 Rome Italy;
Univ Roma Tor Vergata Dept Syst Med Gastroenterol Unit Via Montpellier 1 I-00133 Rome Italy;
Univ Roma Tor Vergata Dept Syst Med Gastroenterol Unit Via Montpellier 1 I-00133 Rome Italy;
Univ Roma Tor Vergata Dept Syst Med Gastroenterol Unit Via Montpellier 1 I-00133 Rome Italy;
bowel preparation; Crohn's disease; inflammatory bowel disease; low-volume bowel preparation; ulcerative colitis;
机译:炎症性肠疾病患者中非常低容量肠道制剂的功效和耐受性
机译:低血液肠疾病患者的疗效,耐受性和安全性和安全性:法国多期面清洁研究
机译:炎症性肠病患者英夫利昔单抗撤退的疗效和耐受性:系统评价和荟萃分析
机译:免疫调节剂在炎症性肠病中的疗效和限制:AzathioPrine,6-巯基嘌呤,甲氨蝶呤和霉酚酸酯Mofetil
机译:肠道制剂对健康受试者中结肠菌细菌植物菌的影响和炎症性肠病患者
机译:新型小剂量柠檬酸盐和西甲硅油肠制剂用于结肠镜检查的有效性和安全性(Clensia):一项多中心随机观察者盲临床试验与小剂量PEG和抗坏血酸(PEG-ASC)的比较
机译:P182炎症性肠病的肠道制剂(IBD):IBD患者中可随机试验评估疗效,耐受性和安全性的初步结果
机译:炎症性肠病进展为癌症:如果没有淋巴管或淋巴结(或促血管生成素2),患者会更好吗?